Asia Pacific Prenatal & Newborn Genetic Testing Market to 2027 - Regional Analysis and Forecasts by Product (Diagnostic, and Screening), Disease Indication (Cystic Fibrosis, Sickle Cell Anemia, Down Syndrome, Phenylketonuria, Recurrent Pregnancy Loss, Antiphospholipid Syndrome (APL), and Other Diseases), Technology (Spectrophotometer, Polymerase Chain Reaction, Fluorescence In-situ Hybridization, Array Comparative Genomic Hybridization, and Others), End User (Hospitals & Clinics, Diagnostic Centers, and Other End User) and Geography


The Asia Pacific prenatal and newborn genetic testing market is expected to reach US$ 1,679.956 Mn in 2027 from US$ 630.914 in 2018. The market is estimated to grow with a CAGR of 11.6% from 2019-2027.
The key factors responsible for the growth of the market in Asia Pacific are rising burden of genetic diseases among infants, increasing fertility rates and developing healthcare scenario with rising awareness among populace regarding the benefits of prenatal testing. On the other hand, use of digital microfluidics in newborn testing is likely to be a prevalent trend in the future years. Soaring birth rates among developing economies are responsible for fueling global baby boom. However, the rising birth rate also contributes to rising birth defects and infants suffering from several genetic diseases. According to a report published by Bill and Melinda Gates Foundation in 2018, there are almost 250 babies born every minute around the globe. Moreover, according to the Centers for Disease Control and Prevention, the fertility rates for Hispanic women was highest in 2017 among Hispanic women with 67.1 births per 1,000 women.
Asian countries such as India and China also have high fertility rates due to factors such as effects of religion, inadequate supply of family welfare services, poverty, and others. According to the World Bank in 2016, the fertility rates in India were reported to be 2.23 births per women as compared to 1.80 in the United States and 1.62 in China. Moreover, neighboring countries, such as Pakistan also have alarming rates of fertility. In 2016, the birth rate in Pakistan was reported to be 3.48 births per woman as per the World Bank data. However, the birthrate in India has successfully reduced its high fertility rate, but still is high as compared to other developed nations. According to the United Nations (UN) report published on June 2019, the fertility rate has reduced to 2.1. Therefore, by 2050 additional 273 million people will be added to India?s population. The increasing number of parturient women across the world are thus likely to create increasing demand for prenatal and newborn genetic tests across the globe leading to the growth of the market. 
The Asia Pacific prenatal and newborn genetic testing market, based on the disease indication was segmented into cystic fibrosis, sickle cell anemia, downs syndrome, phenylketonuria, recurrent pregnancy loss, and Antiphospholipid syndrome, and other diseases. In 2018, Down syndrome segment held the largest share of the market, by disease indication. The highest share of Down syndrome attributes to the high prevalence of this genetic abnormality among fetuses and availability of multiple tests for its screening and diagnostics. However, the sickle cell anemia segment is expected to grow at the fastest rate during the coming year. 
Some of the major primary and secondary sources for prenatal and newborn genetic testing included in the report are Food & Drug Administration (FDA), Indian Institutes of Technology (IITs), International Trade Administration (ITA), Japan Society of Obstetrics and Gynecology (JSOG), Council of Scientific and Industrial Research (cSIR), Pakistan Down Syndrome Association (PDSA) and others.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Product
1.3.2 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Disease Indication
1.3.3 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Technology
1.3.4 Asia Pacific Prenatal and Newborn Genetic Testing Market - By End User
1.3.5 Asia Pacific Prenatal and Newborn Genetic Testing Market - By Country
2. Asia Pacific Prenatal and Newborn Genetic Testing Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Prenatal And Newborn Genetic Testing- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific - PEST Analysis
4.3 Expert Opinions
5. Asia Pacific Prenatal and Newborn Genetic Testing Market - Key Industry Dynamics
5.1 Key Drivers
5.1.1 Burden of Genetic Diseases in India
5.1.2 Increasing Fertility Rate
5.2 Key Restraints
5.2.1 Risks Associated with Prenatal Testing
5.3 Key Opportunities
5.3.1 Development of Policies for Treatment of Rare Diseases
5.4 Future Trends
5.4.1 Digital Microfluidics as New Opportunity Area for Newborn Screening
5.5 Impact Analysis
6. Prenatal And Newborn Genetic Testing Market - Asia Pacific Analysis
6.1 Asia Pacific Prenatal And Newborn Genetic Testing Market Revenue Forecast And Analysis
6.2 Market Positioning
6.3 India Ultrasound Screening Market
6.3.1 Nuchal Translucency
6.3.1.1 Overview
6.3.1.2 Nuchal Translucency Market, revenue and forecast to 2027 (US$ Mn)
6.3.2 Fetal Nasal Bone Assessment
6.3.2.1 Overview
6.3.2.2 Fetal Nasal Bone Assessment Market, revenue and forecast to 2027 (US$ Mn)
6.3.3 Tricuspid Regurgitation
6.3.3.1 Overview
6.3.3.2 Tricuspid Regurgitation Market, revenue and forecast to 2027 (US$ Mn)
6.4 Pricing Analysis
6.5 Asia Pacific Prenatal And Newborn Genetic Testing Market, By Country, Volume And Forecast To 2027
6.5.1 China Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.2 China Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.3 Japan Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.4 Japan Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.5 India Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.6 India Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.7 Thailand Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.8 Thailand Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.9 Malaysia Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.10 Malaysia Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.11 Singapore Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.12 Singapore Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.13 Indonesia Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.14 Indonesia Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.15 Pakistan Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.16 Pakistan Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.17 Bangladesh Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.18 Bangladesh Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.19 Nepal Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.20 Nepal Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
6.5.21 Sri Lanka Screening Market, Volume And Forecast to 2027, By Type (Units)
6.5.22 Sri Lanka Diagnostics Market, Volume And Forecast to 2027, By Type (Units)
7. Prenatal And Newborn Genetic Testing Market, By Product, Analysis And Forecast To 2027
7.1 Overview
7.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Product, 2018 & 2027 (%)
7.3 Diagnostics
7.3.1 Overview
7.3.2 Diagnostics Market, revenue and forecast to 2027 (US$ Mn)
7.3.3 Amniocentesis
7.3.3.1 Overview
7.3.3.2 Amniocentesis Market, revenue and forecast to 2027 (US$ Mn)
7.3.4 Chorionic Villus Sampling
7.3.4.1 Overview
7.3.4.2 Chorionic Villus Sampling Market, revenue and forecast to 2027 (US$ Mn)
7.3.5 Cytogenetic and Pharmacogenetic Testing
7.3.5.1 Overview
7.3.5.2 Cytogenetic and Pharmacogenetic Testing Market, revenue and forecast to 2027 (US$ Mn)
7.4 Screening
7.4.1 Overview
7.4.2 Screening Market, revenue and forecast to 2027 (US$ Mn)
7.4.3 Maternal Serum Screening
7.4.3.1 Overview
7.4.3.2 Maternal Serum Screening Market, revenue and forecast to 2027 (US$ Mn)
7.4.4 Noninvasive Prenatal Testing
7.4.4.1 Overview
7.4.4.2 Noninvasive Prenatal Testing Market, revenue and forecast to 2027 (US$ Mn)
8. Prenatal And Newborn Genetic Testing Market Analysis And Forecast To 2027 - Disease Indication
8.1 Overview
8.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Disease Indication, 2018 & 2027 (%)
8.3 Cystic Fibrosis
8.3.1 Overview
8.3.2 Cystic Fibrosis Market, Revenue And Forecast to 2027 (US$ Mn)
8.4 Sickle Cell Anemia
8.4.1 Overview
8.4.2 Sickle Cell Anemia Market, revenue and forecast to 2027 (US$ Mn)
8.5 Down Syndrome
8.5.1 Overview
8.5.2 Down syndrome Market, revenue and forecast to 2027 (US$ Mn)
8.6 Phenylketonuria
8.6.1 Overview
8.6.2 Phenylketonuria Market, revenue and forecast to 2027 (US$ Mn)
8.7 Recurrent Pregnancy Loss
8.7.1 Overview
8.7.2 Recurrent Pregnancy Loss Market, revenue and forecast to 2027 (US$ Mn)
8.8 Antiphospholipid Syndrome
8.8.1 Overview
8.8.2 Antiphospholipid Syndrome Market, revenue and forecast to 2027 (US$ Mn)
8.9 Other Diseases
8.9.1 Overview
8.9.2 Other Diseases Market, revenue and forecast to 2027 (US$ Mn)
9. Prenatal And Newborn Genetic Testing Market Analysis And Forecast To 2027 - Technology
9.1 Overview
9.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by Technology, 2018 & 2027 (%)
9.3 Spectrophotometer
9.3.1 Overview
9.3.2 Asia Pacific Spectrophotometer Market, Revenue And Forecast To 2027 (US$ Mn)
9.4 Polymerase Chain Reaction
9.4.1 Overview
9.4.2 Polymerase Chain Reaction Market, revenue and forecast to 2027 (US$ Mn)
9.5 Fluorescence In-situ Hybridization
9.5.1 Overview
9.5.2 Fluorescence in-situ Hybridization Market, revenue and forecast to 2027 (US$ Mn)
9.6 Array Comparative Genomic Hybridization Market
9.6.1 Overview
9.6.2 Array Comparative Genomic Hybridization Market, revenue and forecast to 2027 (US$ Mn)
9.7 Others
9.7.1 Overview
9.7.2 Others Market, revenue and forecast to 2027 (US$ Mn)
10. Prenatal And Newborn Genetic Testing Market Analysis And Forecast To 2027 - End User
10.1 Overview
10.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Revenue Share, by End User, 2018 & 2027 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Asia Pacific Hospitals and Clinics Market, Revenue And Forecast To 2027 (US$ Mn)
10.4 Diagnostic Centers
10.4.1 Overview
10.4.2 Diagnostic Centers Market, revenue and forecast to 2027 (US$ Mn)
10.5 Other End Users
10.5.1 Overview
10.5.2 Other End Users Market, Revenue And Forecast To 2027 (US$ Mn)
11. Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 - Geographical Analysis
11.1 Asia Pacific Prenatal And Newborn Genetic Testing Market
11.1.1 Overview
11.1.2 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.1.3 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.1.4 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.1.4.1 Asia Pacific Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.1.4.2 Asia Pacific Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.1.5 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.1.6 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.1.7 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2 Asia Pacific Prenatal and Newborn Genetic Testing Market, Revenue and Forecast to 2027, By Country (%)
11.2.1 China Prenatal And Newborn Genetic Testing Market
11.2.1.1 China Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.1.2 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.1.3 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.1.3.1 China Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.1.3.2 China Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.1.4 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.1.5 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.1.6 China Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.2 Japan Prenatal And New born Genetic Testing Market
11.2.2.1 Japan Prenatal And New Born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.2.2 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.2.3 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.2.3.1 Japan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.2.3.2 Japan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.2.4 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.2.5 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.2.6 Japan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.3 India Prenatal And New born Genetic Testing Market
11.2.3.1 India Prenatal and New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.3.2 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.3.3 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.3.3.1 India Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.3.3.2 India Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.3.4 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.3.5 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.3.6 India Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.4 Pakistan Prenatal And New born Genetic Testing Market
11.2.4.1 Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.4.2 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.4.3 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.4.3.1 Pakistan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.4.3.2 Pakistan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.4.4 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.4.5 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.4.6 Pakistan Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.5 Sri Lanka Prenatal And New born Genetic Testing Market
11.2.5.1 Sri Lanka Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.5.2 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.5.3 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.5.3.1 Sri Lanka Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.5.3.2 Sri Lanka Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.5.4 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.5.5 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.5.6 Sri Lanka Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.6 Bangladesh Prenatal And New born Genetic Testing Market
11.2.6.1 Bangladesh Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.6.2 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.6.3 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.6.3.1 Bangladesh Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.6.3.2 Bangladesh Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.6.4 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.6.5 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.6.6 Bangladesh Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.7 Nepal Prenatal And New born Genetic Testing Market
11.2.7.1 Nepal Prenatal And New born Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.7.2 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.7.3 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.7.3.1 Nepal Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.7.3.2 Nepal Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.7.4 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.7.5 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.7.6 Nepal Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.8 Indonesia Prenatal And Newborn Genetic Testing Market
11.2.8.1 Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.8.2 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.8.3 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.8.3.1 Indonesia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.8.3.2 Indonesia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.8.4 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.8.5 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.8.6 Indonesia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.9 Singapore Prenatal And Newborn Genetic Testing Market
11.2.9.1 Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.9.2 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.9.3 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.9.3.1 Singapore Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.9.3.2 Singapore Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.9.4 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.9.5 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.9.6 Singapore Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.10 Malaysia Prenatal And Newborn Genetic Testing Market
11.2.10.1 Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.10.2 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.10.3 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.10.3.1 Malaysia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.10.3.2 Malaysia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.10.4 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.10.5 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.10.6 Malaysia Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
11.2.11 Thailand Prenatal And Newborn Genetic Testing Market
11.2.11.1 Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027 (US$ Mn)
11.2.11.2 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn)
11.2.11.3 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn)
11.2.11.3.1 Thailand Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.11.3.2 Thailand Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn)
11.2.11.4 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn)
11.2.11.5 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn)
11.2.11.6 Thailand Prenatal and Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn)
12. Prenatal And Newborn Genetic Testing Market - Industry Landscape
12.1 Overview
12.2 Comparative Company Analysis
12.3 Growth Strategies Done by the Companies in the Market, (%)
12.4 Organic Developments
12.4.1 Overview
12.5 Inorganic Developments
12.5.1 Overview
13. Prenatal And Newborn Genetic Testing Market - Key Company Profiles
13.1 LifeCell
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Financial Overview
13.1.4 Product Portfolio
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Quest Diagnostics Incorporated
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Financial Overview
13.2.4 Product Portfolio
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medgenome
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Financial Overview
13.3.4 Product Portfolio
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Eurofins Scientific
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Financial Overview
13.4.4 Product Portfolio
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Metropolis India
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Financial Overview
13.5.4 Product Portfolio
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 SRL Diagnostics
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Financial Information
13.6.4 Product Portfolio
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sandor Lifesciences Pvt. Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Financial Overview
13.7.4 Product Portfolio
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 PerkinElmer, Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Financial Overview
13.8.4 Product Portfolio
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Natera, Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Financial Overview
13.9.4 Product Portfolio
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Laboratory Corporation Of America Holdings (Sequenom)
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Financial Overview
13.10.4 Product Portfolio
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Genes2Me LLP
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Financial Overview
13.11.4 Product Portfolio
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Illumina, Inc.
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Financial Overview
13.12.4 Product Portfolio
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms

LIST OF TABLES Table 1. China Screening Market, Volume And Forecast To 2027, By Type (Units) Table 2. China Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 3. Japan Screening Market, Volume And Forecast To 2027, By Type (Units) Table 4. Japan Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 5. India Screening Market, Volume And Forecast To 2027, By Type (Units) Table 6. India Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 7. Thailand Screening Market, Volume And Forecast To 2027, By Type (Units) Table 8. Thailand Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 9. Malaysia Screening Market, Volume And Forecast To 2027, By Type (Units) Table 10. Malaysia Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 11. Singapore Screening Market, Volume And Forecast To 2027, By Type (Units) Table 12. Singapore Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 13. Indonesia Screening Market, Volume And Forecast To 2027, By Type (Units) Table 14. Indonesia Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 15. Pakistan Screening Market, Volume And Forecast To 2027, By Type (Units) Table 16. Pakistan Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 17. Bangladesh Screening Market, Volume And Forecast To 2027, By Type (Units) Table 18. Bangladesh Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 19. Nepal Screening Market, Volume And Forecast To 2027, By Type (Units) Table 20. Nepal Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 21. Sri Lanka Screening Market, Volume And Forecast To 2027, By Type (Units) Table 22. Sri Lanka Diagnostics Market, Volume And Forecast To 2027, By Type (Units) Table 23. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 24. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 25. Asia Pacific Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 26. Asia Pacific Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 27. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 28. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 29. Asia Pacific Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 30. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 31. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 32. China Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 33. China Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 34. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 35. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 36. China Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 37. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 38. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 39. Japan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 40. Japan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 41. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 42. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 43. Japan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 44. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 45. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 46. India Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 47. India Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 48. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 49. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 50. India Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 51. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 52. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 53. Pakistan Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 54. Pakistan Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 55. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 56. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 57. Pakistan Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 58. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 59. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 60. Sri Lanka Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 61. Sri Lanka Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 62. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 63. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 64. Sri Lanka Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 65. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 66. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 67. Bangladesh Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 68. Bangladesh Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 69. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 70. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 71. Bangladesh Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 72. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 73. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 74. Nepal Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 75. Nepal Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 76. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 77. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 78. Nepal Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 79. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 80. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 81. Indonesia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 82. Indonesia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 83. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 84. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 85. Indonesia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 86. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 87. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 88. Singapore Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 89. Singapore Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 90. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 91. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 92. Singapore Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 93. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 94. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 95. Malaysia Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 96. Malaysia Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 97. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 98. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 99. Malaysia Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 100. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Test Type (US$ Mn) Table 101. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Product (US$ Mn) Table 102. Thailand Screening Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 103. Thailand Diagnostics Market, Revenue And Forecast To 2027, By Type (US$ Mn) Table 104. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Technology (US$ Mn) Table 105. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By Disease Indication (US$ Mn) Table 106. Thailand Prenatal And Newborn Genetic Testing Market, Revenue And Forecast To 2027, By End User (US$ Mn) Table 107. Organic Developments Done By Companies Table 108. Inorganic Developments Done By Companies Table 109. Glossary of Terms, Prenatal And Newborn Genetic Testing Market

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

Other Reports by The Insight Partners

Europe Carbon Fiber Market to 2027 - Regional Analysis and Forecasts By Precursor (PAN based, Pitch); Form (Composite, Non-Composite); End Use Industry (Automotive, Aerospace and Defense, Construction, Sporting Goods, Wind Energy, Others), and Countries

The Europe carbon fiber market is accounted to US$ 724.5 Mn in 2018 and is expected to grow at a CAGR of 9.9% during the forecast period 2019 - 2027, to account to US$ 1,669.1 Mn by 2027. The Europe carbon fiber market is segmented on the basis of pr...

North America Household Insecticides Market to 2027 - Regional Analysis and Forecasts By Insect Type (Mosquitoes & Flies, Rats & other Rodents, Termites, Bedbugs & Beetles, Others); Composition (Natural, Synthetic); Packaging (Small, Medium, Large); Distribution Channel (Supermarket/Hypermarket, Convenience Stores, Online Store, others)

The North America household insecticides market is accounted to US$ 2245.1 Mn in 2018 and is expected to grow at a CAGR of 5.5% during the forecast period 2019 - 2027, to account to US$ 3610.3 Mn by 2027. The North America household insecticides mark...

Europe Household Insecticides Market to 2027 - Regional Analysis and Forecasts By Insect Type (Mosquitoes & Flies, Rats & other Rodents, Termites, Bedbugs & Beetles, Others); Composition (Natural, Synthetic); Packaging (Small, Medium, Large); Distribution Channel (Supermarket/Hypermarket, Convenience Stores, Online Store, others)

The Europe household insecticides market is accounted to US$ 2,005.9 Mn in 2018 and is expected to grow at a CAGR of 5.4% during the forecast period 2019 - 2027, to account to US$ 3,184.5 Mn by 2027. The Europe household insecticides market is segmen...

Asia Pacific Household Insecticides Market to 2027 - Regional Analysis and Forecasts By Insect Type (Mosquitoes & Flies, Rats & other Rodents, Termites, Bedbugs & Beetles, Others); Composition (Natural, Synthetic); Packaging (Small, Medium, Large); Distribution Channel (Supermarket/Hypermarket, Convenience Stores, Online Store, others)

The Asia pacific household insecticides market is accounted to US$ 6,364.7 Mn in 2018 and is expected to grow at a CAGR of 5.2% during the forecast period 2019 - 2027, to account to US$ 9,997.7 Mn by 2027. The Asia pacific household insecticides mark...

Asia Pacific Carbon Fiber Market to 2027 - Regional Analysis and Forecasts By Precursor (PAN based, Pitch); Form (Composite, Non-Composite); End Use Industry (Automotive, Aerospace and Defense, Construction, Sporting Goods, Wind Energy, Others), and Countries

The APAC carbon fiber market is accounted to US$ 988.2 Mn in 2018 and is expected to grow at a CAGR of 12.4% during the forecast period 2019 - 2027, to account to US$ 2,794.8 Mn by 2027. The APAC carbon fiber market is segmented on the basis of precu...

New Biotechnology Reports

Publisher: The Insight Partners